Advances in Plant-Sourced Natural Compounds as Anticancer Agents, 2nd Edition
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Natural Products Chemistry".
Deadline for manuscript submissions: 31 May 2026 | Viewed by 207
Special Issue Editors
Interests: plant/lichen secondary metabolites-identification and pharmacological potential; phenolic compounds; antibiotics; antimicrobial activity; in vitro anticancer activity; oral cancer; ROS; oxidative stress; antioxidants/pro-oxidants; healthcare; health environment; foods; diet analysis; nutrition; nutritional supplements; case studies
Special Issues, Collections and Topics in MDPI journals
Interests: pharmaceutical technology; cyclodextrin inclusion complexes; drug delivery systems; biopharmaceuticals; pharmaceutical processes; drug release profiles; drug design; development, optimization and manufacturing of pharmaceutical products; pre- and post-compression parameters for solid dosage forms; preformulation studies on pharmaceuticals; physico-chemical characterization of materials; quality of pharmaceutical forms
Special Issues, Collections and Topics in MDPI journals
Interests: pharmacognosy; phytochemistry and phytotherapy; phytochemical analyses' spectrophotometry; HPLC; obtaining plant extracts; standardization; determining extract stability; antioxidant action; phytotherapeutic formulations; correlations between chemical composition and therapeutic action; drug interactions
Special Issues, Collections and Topics in MDPI journals
Interests: pharmaceutical forms manufacturing; drug preformulation and formulation; drug release; biopharmaceutical charcterization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
After the great success of this Special Issue‘s first edition, we are pleased to inform you that Molecules will launch the second edition of “Advances in Plant-Sourced Natural Compounds as Anticancer Agents”.
https://www.mdpi.com/journal/molecules/special_issues/Q6661R9V2K
Cancer is among the leading causes of death worldwide. Generally, cancer rates are highest in countries with populations that have the highest life expectancy, education level, and standard of living. The principal purpose of current cancer therapy is to perturb or kill the malignant cells from early-stage neoplasms or those remaining after surgery without affecting the normal cytophysiological processes, and to trigger immune defense against residual tumor cells. Natural products are rich sources of bioactive molecules for new anticancer drugs. Phytochemicals show great potential in improving the clinical condition of cancer patients, as demonstrated by numerous preclinical and clinical studies. Plant-sourced natural compounds have diverse biological activities, including antioxidant and anticancer effects. Recently, many emerging studies have revealed the uses of plant-sourced natural compounds and individual anticancer drugs that could be promising combinations in hampering multiple signaling pathways involved in cancer development and progression. In addition to enhancing the therapeutic efficacy, this has also been proven to reduce the dosage of chemotherapeutic drugs, overcoming multiple drug resistance and minimizing treatment side effects. This Special Issue focuses on recent research regarding plant-sourced natural compounds with anticancer activity through various mechanisms and novel pharmaceutical formulations with potential applications in prophylaxis and the treatment of neoplasia.
Dr. Violeta Popovici
Dr. Emma Adriana Ozon
Prof. Dr. Cerasela Elena Gîrd
Prof. Dr. Dumitru Lupuliasa
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal plants
- natural compounds
- phytochemicals
- antioxidant activity
- anticancer activity
- phytotherapy
- drug discovery
- drug delivery
- pharmaceutical formulation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
